Molecular Physiology of the Thiazide-sensitive Sodium-chloride Cotransporter
Overview
Nephrology
Authors
Affiliations
Purpose Of Review: This review summarizes recent advances in the understanding of the molecular physiology and regulation of the thiazide-sensitive sodium-chloride cotransporter (NCC).
Recent Findings: Mutations of with-no-lysine (WNK) kinases 1 and 4 result in hyperactivity of NCC and familial hyperkalemic hypertension, a genetic syndrome of hypertension. Recent studies have shown that WNK1 and WNK4 activate the STE20 family protein kinases Ste20-related proline/alanine-rich kinase and odd-skipped-related 1, resulting in phosphorylation and activation of NCC. Additionally, a mouse knock-in model for a WNK4 familial hyperkalemic hypertension mutant demonstrated increased Ste20-related proline/alanine-rich kinase/odd-skipped-related 1 and NCC phosphorylation. It is unclear how these studies fit with the data indicating that WNK4 inhibits NCC, and the familial hyperkalemic hypertension mutations of WNK4 are loss-of-function mutations. Another WNK kinase, WNK3, also regulates NCC, activating NCC and antagonizing the effect of WNK4. Extracellular signal-related kinase 1/2 mitogen-activated protein kinase activation by Ras guanyl nucleotide-releasing protein 1 is another kinase pathway that appears to be a potent regulator of NCC. Other studies have described a role for angiotensin II in pressure natriuresis via actions on NCC. Recent studies examining the hormonal regulation of NCC have implicated angiotensin II and aldosterone in regulation of the WNK4-Ste20-related proline/alanine-rich kinase-NCC pathway.
Summary: NCC is subject to a complex regulatory network of kinases, which appear quite sensitive to alterations of the hormonal and physiologic milieu.
Rioux A, Nsimba-Batomene T, Slimani S, Bergeron N, Gravel M, Schreiber S Physiol Rev. 2024; 104(3):1147-1204.
PMID: 38329422 PMC: 11381001. DOI: 10.1152/physrev.00027.2023.
Aldosterone: Renal Action and Physiological Effects.
Johnston J, Welch A, Cain B, Sayeski P, Gumz M, Wingo C Compr Physiol. 2023; 13(2):4409-4491.
PMID: 36994769 PMC: 11472823. DOI: 10.1002/cphy.c190043.
Molecular Mechanisms of Na-Cl Cotransporter in Relation to Hypertension in Chronic Kidney Disease.
Liang L, Shimosawa T Int J Mol Sci. 2023; 24(1).
PMID: 36613730 PMC: 9820686. DOI: 10.3390/ijms24010286.
Pushpakumar S, Ahmad A, Ketchem C, Jose P, Weinman E, Sen U Life Sci. 2020; 243:117226.
PMID: 31904366 PMC: 7015806. DOI: 10.1016/j.lfs.2019.117226.
Wu A, Wolley M, Stowasser M J Hum Hypertens. 2019; 33(7):508-523.
PMID: 30723251 DOI: 10.1038/s41371-019-0170-6.